Karuna Mittal

Karuna Mittal joined Prelude as Director Research and Development in August 2021. Karuna has extensive research experience in biomarker and novel targeted therapy discovery in different tumor types, including breast, prostate, pancreatic, ovarian, and head and neck. She has served as a peer reviewer and has published her research in high-impact journals. Before joining PreludeDx, Karuna was a postdoctoral fellow at Emory University, identifying novel targeted therapies in rare pediatric cancers.

Karuna holds a Master’s in Science (Human Physiology, Medicine) from Health Science University Rajasthan, India, and did her Ph.D. in Cellular and molecular biology from Georgia State University, Atlanta.